trans-1-(4-(4-(Trifluoromethyl)phenoxy)cyclohexyl)-3-(3-(trifluoromethyl)phenyl)urea

ID: ALA3098149

Max Phase: Preclinical

Molecular Formula: C21H20F6N2O2

Molecular Weight: 446.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cccc(C(F)(F)F)c1)N[C@H]1CC[C@H](Oc2ccc(C(F)(F)F)cc2)CC1

Standard InChI:  InChI=1S/C21H20F6N2O2/c22-20(23,24)13-4-8-17(9-5-13)31-18-10-6-15(7-11-18)28-19(30)29-16-3-1-2-14(12-16)21(25,26)27/h1-5,8-9,12,15,18H,6-7,10-11H2,(H2,28,29,30)/t15-,18-

Standard InChI Key:  MFRDVPYKJUYMDN-RZDIXWSQSA-N

Molfile:  

     RDKit          2D

 31 33  0  0  0  0  0  0  0  0999 V2000
   10.1146  -14.1907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1134  -15.0180    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8282  -15.4309    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5446  -15.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5417  -14.1871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8264  -13.7779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2546  -13.7719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9706  -14.1817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6835  -13.7665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9737  -15.0067    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3994  -14.1763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4002  -15.0044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1121  -15.4140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8273  -15.0025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8262  -14.1765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1098  -13.7622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5418  -15.4149    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2563  -15.0025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9677  -15.4152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6818  -15.0035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6822  -14.1777    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9627  -13.7653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2517  -14.1795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8280  -16.2558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1135  -16.6681    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.5423  -16.6685    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.8201  -17.0781    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.3961  -13.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1110  -14.1758    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.3950  -12.9394    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   20.1071  -13.3450    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 11  9  1  6
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  1  1
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  3 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
 21 28  1  0
 28 29  1  0
 28 30  1  0
 28 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3098149

    ---

Associated Targets(Human)

EIF2AK1 Tchem Eukaryotic translation initiation factor 2-alpha kinase 1 (688 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

NIH3T3 (5395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Eif2ak1 Eukaryotic translation initiation factor 2-alpha kinase 1 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.39Molecular Weight (Monoisotopic): 446.1429AlogP: 6.24#Rotatable Bonds: 4
Polar Surface Area: 50.36Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.30CX Basic pKa: CX LogP: 5.60CX LogD: 5.60
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.55Np Likeness Score: -1.19

References

1. Chen T, Takrouri K, Hee-Hwang S, Rana S, Yefidoff-Freedman R, Halperin J, Natarajan A, Morisseau C, Hammock B, Chorev M, Aktas BH..  (2013)  Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase.,  56  (23): [PMID:24261904] [10.1021/jm400793v]
2. Yefidoff-Freedman R, Fan J, Yan L, Zhang Q, Dos Santos GRR, Rana S, Contreras JI, Sahoo R, Wan D, Young J, Dias Teixeira KL, Morisseau C, Halperin J, Hammock B, Natarajan A, Wang P, Chorev M, Aktas BH..  (2017)  Development of 1-((1,4-trans)-4-Aryloxycyclohexyl)-3-arylurea Activators of Heme-Regulated Inhibitor as Selective Activators of the Eukaryotic Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response.,  60  (13): [PMID:28590739] [10.1021/acs.jmedchem.7b00059]

Source